HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Hem/oncs toe ‘line in the sand’ between quest for cure, overly aggressive end-of-life care
-
- Changes to immigration, health policies will create economic havoc, increase ‘human cost’ Barbara A. Burtness, MD
- Progress has been slow to realize potential of molecular imaging in precision oncology Wafik S. El-Deiry, MD, PhD, FACP
- American Cancer Society elects new board members, officers
- Brigham and Women’s Hospital geneticist wins Breakthrough Prize
- Cancer centers endorse shortened HPV vaccine series, emphasize need for physician advocacy
- CMS expands opportunities under the Quality Payment Program
- Community Oncology Alliance elects officers
- International Association for the Study of Lung Cancer presents award
-
- Ludwig Institute for Cancer Research appoints scientific director
- Momelotinib provides ‘some treatment benefit’ to patients with myelofibrosis
- Seattle Cancer Care Alliance presents nursing scholarships
- Study results do not support age cutoff for mammography
- Trial of quisinostat in ovarian cancer meets primary endpoints
- Virtual reality initiative benefits adolescents, young adults with cancer
- Despite challenges in US cancer care, things could be a lot worse John Sweetenham, MD, FRCP, FACP
- FDA clears application for SB-525 gene therapy program for hemophilia A
-
- FDA grants orphan drug designation to ABTL0812 for pancreatic cancer
- FDA grants priority review to niraparib for gynecologic cancers
- FDA grants priority review to Stivarga for second-line treatment of HCC
- FDA grants two indications to Adynovate for hemophilia A
- FDA removes full clinical hold on pacritinib
- HPV–associated oropharyngeal cancer on rise among women, nonwhites
- Anti–PD-1 antibodies appear safe in patients with pre-existing autoimmunity
- Blood donors do not transmit neurodegenerative diseases to transfusion recipients
-
- BMI, waist circumference, type 2 diabetes associated with risk for liver cancer
- Collaboration needed to make molecular imaging a reality for precision oncology
- First-line cabozantinib shows significant benefit over sunitinib for metastatic kidney cancer
- Long-term adjuvant endocrine therapy reduces contralateral breast cancer risk in community setting
- Lymph node involvement prognostic for survival in NSCLC, M1a disease
- Modern radiologists face no increased risk of cancer, death
- Blu-285 demonstrates activity in advanced systemic mastocytosis
- Brentuximab vedotin improves CTCL outcomes over methotrexate, bexarotene
-
- Down syndrome does not impact treatment outcomes among children with ALL
- First-line obinutuzumab significantly prolongs PFS in follicular lymphoma
- GRAALL 2005: Age 55 years may be limit for pediatric regimens in ALL
- Hypomethylating agents improve outcomes for older patients with CMML
- IKZF1 genetic variants may predispose children to ALL
- Moderate exercise may prolong OS in patients with metastatic colorectal cancer
- MRD may more accurately assess remission than morphology in ALL
- PET scans could offer alternative route for treatment of esophageal cancer
-
- Portable device rapidly assesses blood clotting
- Preoperative anemia management clinics may reduce number of blood transfusions
- Researchers develop artificial red blood cells for potential transfusion alternative
- Watch-and-wait approach may be alternative to surgery for certain patients with rectal cancer
- ZUMA-1: Anti-CD19 CAR T cells show clinical benefit in DLBCL
- Is hospitalization within the final 30 days of life appropriate for patients with hematologic malignancies?